Perplexity listed its AI-powered Comet browser for iPhone pre-order on the App Store, with a scheduled release date of March 11. The move brings the company’s flagship browsing tool to Apple’s mobile ecosystem for the first time, extending its challenge to Safari and Google Chrome on what Perplexity CEO Aravind Srinivas has called a “key battleground” for AI-driven browsing. Read...
Read MoreMaolac is a biotech company developing a new class of bio-functional protein ingredients inspired by the composition of human breast milk. Using AI-driven proteomics, Maolac identifies and concentrates highly targeted proteins from bovine colostrum to deliver potent, low-dose solutions for gut health, mobility, recovery, immune balance, and healthy aging. Their ingredients are designed for real-world food and nutrition applications, offering strong stability, neutral taste, and flexible formulation options. Read...
Read More“Israeli company Ossio is setting up a second plant in Palmetto, Florida and hiring 100 employees.” This item in the local media came as a surprise. Ossio has barely featured in the Israeli media and has grown unnoticed. The company currently has 265 employees including 100 in Caesarea. To date Ossio has raised more than $100 million and several days ago the company received a credit line of $50 million. Revenue is expected to reach $60 million in 2026 and the company is considering an IPO in the coming years. Read...
Read MoreOn the morning of June 28, the twin smokestacks of the Bull Run Fossil Plant in Claxton, Tennessee, crumbled to the ground after 61 years of service. However, this wasn’t just another emblem of a dying energy industry—it represented the birth of an exciting new chapter in electricity generation. Read...
Read MoreRIYADH, Saudi Arabia, Feb. 18, 2026 /PRNewswire/ — HUMAIN, a PIF company delivering full-stack artificial intelligence capabilities globally, today announced a $3 billion strategic investment in xAI as part of the company’s Series E financing round. The transaction represents a significant, end-to-end capital deployment for HUMAIN, reflecting continued momentum in its long-term investment strategy focused on category-defining technology platforms. Read...
Read More
